Clarus Ventures, LLC - AERIE PHARMACEUTICALS INC ownership

AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 76 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Clarus Ventures, LLC ownership history of AERIE PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2015$1,534,000
+37.2%
63,0170.0%1.08%
+67.2%
Q3 2015$1,118,000
-98.9%
63,017
-98.1%
0.64%
-97.7%
Q4 2014$97,438,000
+35.8%
3,338,067
-3.8%
27.82%
-2.9%
Q3 2014$71,763,000
-16.5%
3,468,4950.0%28.64%
-6.1%
Q2 2014$85,915,000
+16.9%
3,468,4950.0%30.50%
+43.4%
Q1 2014$73,497,000
+18.0%
3,468,4950.0%21.26%
+20.8%
Q4 2013$62,294,0003,468,49517.60%
Other shareholders
AERIE PHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
LEVIN CAPITAL STRATEGIES, L.P. 1,373,542$15,658,0001.56%
DAFNA Capital Management LLC 289,040$3,295,0000.87%
Integral Health Asset Management, LLC 250,000$2,850,0000.82%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 193,266$2,203,0000.80%
PFM Health Sciences, LP 2,182,684$24,883,0000.73%
DCF Advisers, LLC 136,501$1,556,0000.69%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,977,020$33,938,0000.66%
NEXPOINT ASSET MANAGEMENT, L.P. 309,778$3,532,0000.61%
Rhenman & Partners Asset Management AB 750,000$8,550,0000.60%
RICE HALL JAMES & ASSOCIATES, LLC 1,232,600$14,052,0000.52%
View complete list of AERIE PHARMACEUTICALS INC shareholders